Stocks/RGNX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

RGNX

ACCE Researched
REGENXBIO Inc. Common Stock
HealthcareBiotechnologyNASDAQ
$9.12
+1.67%today
MKT CAP
$471M
NEXT EARNINGS
Mar 5
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.